Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
As of July 2025, IQVIA estimated more than 2 million UK adults were paying out of pocket for anti-obesity medications, against approximately 220,000 receiving them through the NHS: a ratio of around nine to one
Retatrutide is not FDA-approved and cannot be prescribed in Florida or any other state
Many patients on GLP-1 medications are already vitamin D deficient before starting treatment, as obesity itself is associated with lower vitamin D levels due to sequestration in adipose tissue
The risk of reduced potency or contamination is not worth the savings from squeezing out a few extra doses
Canonical sampling through velocity rescaling
US$ 25.40
US$ 21.05
US$ 22.02
US$ 21.36
US$ 20.40
